ArticleNPJ breast cancer2023

A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN).

Foluso O Ademuyiwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.